摘要
目的:用HPLC-ESI-MSn法分离和鉴定国产盐酸克林霉素棕榈酸酯原料药中的10种杂质,并探讨这些杂质的质谱裂解规律。方法:采用Agilent ZORBAX SB-C8色谱柱(150 mm×3.0 mm,3.5μm),流动相为5 mmol.L-1醋酸铵溶液-乙腈(25∶75),在正离子检测方式下,AB SCIEX 4000 Q TRAP LC/MS/MS仪对盐酸克林霉素棕榈酸酯中的杂质进行在线多级质谱分析。结果:通过多级质谱裂解推断盐酸克林霉素棕榈酸酯原料药中10种杂质分别为克林霉素、丙叉克林霉素、亚砜克林霉素棕榈酸酯、克林霉素十二酸酯、棕榈酸乙酯、克林霉素十四酸酯、克林霉素B棕榈酸酯、表克林霉素棕榈酸酯、克林霉素十八酸酯、丙叉克林霉素棕榈酸酯。结论:鉴定了盐酸克林霉素棕榈酸酯原料药中10个杂质的结构,其中3个杂质为新的杂质。
Objective:Ten impurities in clindamycin palmitate hydrochloride drug substances made in China were separated and identified by HPLC - ESI - MSn method. The fragmentation patterns and structural assignment of these impurities were studied, Methods: Agilent ZORBAX SB - C8 column ( 150 mm×3.0mm,3.5μm) was used with a mobile phase of 5 mmol · L^- 1 ammonium acetate solution -acetonitrile(25:75 ). In positive mode, the impu- rities in clindamycin palmitate hydrochloride were analyzed by AB SCIEX 4000 Q TRAP LC/MS/MS. The complete fragmentation patterns of ten impurities were studied by MSn and used to obtain information about the structure of these impurities. Results:The ten impurities in clindamycin palmitate hydroehloride drug substances were deduced based on the HPLC -MSn data as clindamycin, anisylidene clindamycin, clindamycin palrnitate sulphoxides, clinda- mycin laurate, ethyl palmitate, clindamycin myristate, clindamycin B - palmitate, epiclindamycin palmitate, clinda- mycin stearate, anisylidene clindamycin palmitate. Conclusion: The structures of ten impurities in clindamycin pal- mitate hydrochloride drug substances were identified, of which three impurities were new impurities.
出处
《药物分析杂志》
CAS
CSCD
北大核心
2012年第12期2213-2220,共8页
Chinese Journal of Pharmaceutical Analysis
基金
国家药典委员会国家药品标准提高研究项目(国药典化发[2010]84号)